BIO-Europe Spring 2026

Evogene Ltd. will present its latest advances in small-molecule discovery for drug development at @BIO-Europe Spring 2026, taking place March 23–25 in Lisbon (Theatre A).
Evogene’s VP of Business Development, Dr. Olga Nissan, will highlight recent breakthroughs in AI-driven small-molecule design and discuss how ChemPass AI™, our unique tech-engine, is opening new opportunities for collaborative drug development.
Evogene’s Chief Development Officer, Dr. Gabi Tarcic, together with Dr. Nissan, will be available for one-on-one meetings during the event